Merger Arbitrage Risk: What Happens to Shareholders When a Deal Doesn't Close
When a company agrees to be acquired, its stock typically moves toward the announced offer price within hours, then stalls short of it. This gap reflects the market's ongoing estimate of deal-completion risk: the probability that a signed agreement never reaches closing.
For shareholders holding a target company's stock, this gap carries the central lesson of the transaction. A merger agreement signals intent, not a guaranteed outcome, and investors who treat it as the latter are often caught unprepared when regulators, lenders, or the target's own shareholders derail a deal before it closes.
Why Target Company Shares Don't Fully Reflect the Deal Price?
The gap between a target's trading price and the offer price is known as the arbitrage spread. It exists because the market never assigns a pending deal full certainty of closing. A narrow spread of one or two points signals broad confidence in an on-schedule completion, while a spread of five, eight, or more points signals genuine doubt, usually tied to antitrust exposure, financing conditions, or a shareholder vote whose outcome is not yet assured.
This same spread forms the foundation of merger arbitrage as an investment strategy. Investors purchase the target's stock after the announcement to capture the spread if the deal closes, effectively betting on completion rather than on the underlying business itself. Historical studies of announced cash mergers generally place completion rates between 80% and 95%, depending on the period and deal type examined. In other words, a meaningful share of announced deals never reaches completion, and that risk is precisely what the spread prices are.
What Can Cause a Merger to Fall Through?
Four categories account for most collapsed deals.
Regulatory or antitrust rejection is the most visible of these: a transaction that consolidates market share in a way regulators consider anticompetitive can be blocked outright or rendered commercially unworkable through required divestitures.
Financing failure, meanwhile, affects leveraged deals most severely, particularly private-equity-backed transactions that depend on credit markets remaining cooperative months after signing.
Shareholder vote failure represents a real, though less common, risk. Target shareholders must approve the deal under SEC proxy disclosure rules, and the vote can fail if enough shareholders object to the price or terms offered.
Beyond the vote itself, a material adverse change clause or a superior competing bid emerging before closing can also unwind an agreement that appeared settled only weeks earlier.
What Happens to Shareholders If the Deal Collapses
Understanding what happens if a merger fails starts with separating two costs: the cost to the company and the cost to the shareholder who bought in expecting a close. The shareholder-side pattern is consistent across most failed transactions.
The target's stock gives back most or all of the acquisition premium, often falling toward or below its pre-announcement level, and anyone who purchased shares after the announcement absorbs that decline directly.
The M&A termination fee built into most agreements does not change this outcome for shareholders. These fees, paid when a deal collapses for specified reasons, typically amount to the low single digits of transaction value, while reverse termination fees, paid by the buyer and usually triggered by regulatory failure, run considerably higher.
When Amazon's bid for iRobot collapsed in early 2024 over EU antitrust objections, Amazon paid iRobot a reported $94 million termination fee, roughly 6.7% of the deal value. That payment supported iRobot's business operations, not the shareholders who had bought in near Amazon's offer price, and iRobot's stock fell sharply on the news.
How Deal Terms Affect the Risk Shareholders Are Taking On
Comparing a specific transaction's disclosed terms with how a routine, unconstrained acquisition typically resolves provides investors with a useful reference point. This baseline, often covered in explainers on what happens to shareholders when a company is acquired, shows how far a particular deal's risk profile departs from the norm before turning to the deal-specific terms that usually explain the difference.
These terms remain the clearest signal available to investors. A larger reverse termination fee generally indicates that the seller's board pushed hard for protection against financing or regulatory failure, which, in turn, suggests the board recognized a real completion risk worth pricing into the contract.
Financing contingencies, or the absence of them, matter just as much. An all-cash deal backed by committed financing from a syndicate of lenders follows a very different timeline than one that is still waiting for a debt raise to materialize. Neither term directly protects the share price; both simply describe how much risk the two companies agreed to bear.
How Merger Arbitrage Investors Evaluate These Risks
Professional merger arbitrage investors size their positions much as an underwriter prices risk, weighing the width of the spread against their own estimate of the probability of completion rather than the headline return alone. A ten-point spread on a deal estimated at 95% completion odds represents a very different bet than the same spread on a deal facing a contested antitrust review.
The inputs behind that estimate remain fairly consistent across the industry: the regulatory environment for the specific sector, the acquirer's financing structure and leverage, historical completion rates for comparable deal types, and any public signs of shareholder resistance.
Retail investors who hold shares without running this kind of analysis face the same downside exposure; the difference is that they have not sized their positions for it. That distinction, more than any other, separates holding a stock through a pending deal from actively trading the spread.
What Shareholders Should Watch For After a Deal Is Announced
Three signals tend to move first when a deal is heading toward trouble. Regulatory filing updates and antitrust review milestones, such as a second request from antitrust regulators or a formal objection from a foreign competition authority, usually provide the earliest and clearest warning. Shareholder vote dates, together with any public opposition from large institutional holders ahead of that vote, are worth tracking directly rather than assuming approval is routine.
Financing commitment updates from the acquiring company round out the list, particularly in deals financed substantially with debt. A lender pulling back or a credit downgrade tied to the transaction tends to widen the spread well before the deal is formally at risk. None of these signals guarantees an outcome on its own, but together they explain most of the spread movement that shareholders observe between the announcement and the close.
Conclusion
An announced merger is a proposal with real momentum behind it, not a completed transaction, and the gap between a target's trading price and the deal price reflects exactly that distinction.
Shareholders who understand what drives that gap, namely regulatory odds, financing conditions, and the shareholder vote itself, read share price movement after an announcement far more accurately than those who treat a signed agreement as a formality.
The M&A termination fee, the financing structure, and the historical base rate for the specific deal type all feed into that assessment, and none of them offer a shortcut around it.
As antitrust scrutiny has intensified across major economies and financing conditions have grown less predictable, understanding merger arbitrage risk has become relevant well beyond the professional arbitrage community. It now shapes how any shareholder should read the stock they hold once the announcement headlines fade and the deal enters its months-long path toward closing or toward collapse.
